EU project to launch five RFID pilot tests

Following a year of research and development, the EU-funded BRIDGE project is now preparing five pilots to test Electronic Product Code (EPC) and Radio Frequency Identification (RFID) technologies.

The pilots, scheduled to start in September, will test RFID across several sectors of industry including retail, pharmaceutical, manufacturing, distribution and logistics, and services.

The Electronic Product Code (EPC) is a family of coding schemes created to succeed the bar code. It was created as a low-cost method of tracking goods using RFID technology. RFID is a method of identifying unique items using radio waves. Typically, a reader communicates with a tag, which holds digital information in a microchip.

BRIDGE (Building Radio frequency IDentification solutions for the Global Environment) is a three-year €7.5 million project funded under the EU's Sixth Framework Programme (FP6). It is made up of a consortium of 30 partners from the worlds of industry and research.

BRIDGE was created to research, develop and implement tools enabling RFID and EPCglobal applications, as well as to drive the acceptance of EPCglobal standards in Europe.

The first pilot to go live will test the use of EPC second-generation technology to track pallets of pharmaceutical products as they move through the supply chain, from the manufacturers through distributor networks and on to hospitals and pharmacies.

"The purpose of the pilot is to use RFID to know where the goods come from, and where they are at any given moment," said Henri Barthel, the coordinator of the BRIDGE project. "With RFID, the idea is that the technology can help companies manage the supply chain in a much more accurate and efficient manner."

The pilot will aim to trace a number of products, identified at the carton and pallet levels using EPC RFID tags and 2-D bar-code labels. According to the organisers, deploying this 'hybrid environment' of RFID and bar-coding will afford them the chance to discover the pros and cons of each technology. In addition to RFID tags and 2-D bar-code labels, the pilot will incorporate a network-based system allowing the participants in the project to store, access and analyse all data collected during the experiment.

Ultimately, the objective of the pilot will be to increase the safety of patients by improving the traceability of pharmaceutical products and certifying the pedigree or authenticity of these as they move from the manufacturer to the final user.

Another pilot will be in the retail sector where BRIDGE will test the use of second generation EPC RFID to track cartons and pallets of clothing from the point of manufacture to the store. The pilot will track the goods as they move across the supply chain, but could also include novel in-store applications such as using RFID tags to identify individual garments, and installing RFID interrogators in dressing rooms so shoppers could obtain detailed product information about the items they are trying on, such as sizes, prices and availability.

Lastly, three more similar pilots will take place in food manufacturing processes, reusable assets and products in-service. The results of all five pilots will be made available by the project as it seeks to promote the uptake of standardised EPC and RFID technology for use in global supply chains.

"Since its inception, RFID has been hailed as the panacea for a more sophisticated and efficient global supply chain," said Mr Barthel. "The BRIDGE project will transform RFID from being an identification technology into providing an EPCglobal based product information network."

For further information, please visit:
http://www.bridge-project.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...